Extended-release buprenorphine is approved as a once-monthly subcutaneous injection for the treatment of moderate-to-severe ...
Geneticist Michael Klotsman was frustrated by human drug development. That led him to launch a startup focused on treatments ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback